Evidence map›Paper›PMID 37627250›Full record

ReviewBiomolecules2023

MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases.

Chao Chen, Mengmeng Guo, Xu Zhao, Juanjuan Zhao, Longqing Chen, Zhixu He, Lin Xu, Yan Zha

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chao ChenSchool of Medicine, Guizhou University, Guiyang 550025, China.
Mengmeng GuoDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Xu ZhaoDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Juanjuan ZhaoDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Longqing ChenDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Zhixu HeCollaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi 563000, China.
Lin XuDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0002-6889-0279
Yan ZhaSchool of Medicine, Guizhou University, Guiyang 550025, China.ORCID 0000-0002-8713-1665
Zunyi Medical University · CNGuizhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are a class of small noncoding RNA that can regulate physiological and pathological processes through post-transcriptional regulatory gene expression. As an important member of the miRNAs family, microRNA-7 (miR-7) was first discovered in 2001 to play an important regulatory role in tissue and organ development. Studies have shown that miR-7 participates in various tissue and organ development processes, tumorigenesis, aging, and other processes by regulating different target molecules. Notably, a series of recent studies have determined that miR-7 plays a key regulatory role in the occurrence of inflammation and related diseases. In particular, miR-7 can affect the immune response of the body by influencing T cell activation, macrophage function, dendritic cell (DC) maturation, inflammatory body activation, and other mechanisms, which has important potential application value in the intervention of related diseases. This article reviews the current regulatory role of miR-7 in inflammation and related diseases, including viral infection, autoimmune hepatitis, inflammatory bowel disease, and encephalitis. It expounds on the molecular mechanism by which miR-7 regulates the occurrence of inflammatory diseases. Finally, the existing problems and future development directions of miR-7-based intervention on inflammation and related diseases are discussed to provide new references and help strengthen the understanding of the pathogenesis of inflammation and related diseases, as well as the development of new strategies for clinical intervention.

Indexed as

EncephalitisInflammatory Bowel DiseasesMicroRNAsRNA, Small UntranslatedHumansInflammationMicroRNAsMIRN7-1 microRNA, humanRNA, Small Untranslatedimmune responseinflammationinterventionmicroRNA-7T cells

Identifiers

PMID37627250
PMCPMC10452300
OpenAlexW4385423366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.